Literature DB >> 10817734

Antibiotic susceptibility patterns of Neisseria meningitidis isolates from patients and asymptomatic carriers.

L Arreaza1, L de La Fuente, J A Vázquez.   

Abstract

The activities of seven antimicrobial agents used for treatment and prophylaxis of meningococcal disease was investigated against 901 Neisseria meningitidis isolates, 112 of which were recovered from patients and 789 of which were recovered from asymptomatic carriers. The proportions of isolates with decreased susceptibility to penicillin were 55.3 and 39.0%, respectively. Penicillin- and ampicillin-intermediate strains were more common among serogroup C meningococci than among non-serogroup C meningococci from both patients and carriers.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10817734      PMCID： PMC89938          DOI： 10.1128/AAC.44.6.1705-1707.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Cloning and characterization of a DNA fragment that confers sulfonamide resistance in a serogroup B, serotype 15 strain of Neisseria meningitidis.

Authors:  B E Kristiansen; P Rådström; A Jenkins; E Ask; B Facinelli; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics.

Authors:  J S Bradley; J D Connor
Journal:  Pediatr Infect Dis J       Date:  1991-11       Impact factor: 2.129

3.  Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Authors:  W R Gransden; C A Warren; I Phillips; M Hodges; D Barlow
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

4.  Penicillin-resistant beta-lactamase producing Neisseria meningitidis in Spain.

Authors:  D Fontanals; V Pineda; I Pons; J C Rojo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

5.  Spread of penicillinase-producing and transfer plasmids from the gonococcus to Neisseria meningitidis.

Authors:  J R Dillon; M Pauzé; K H Yeung
Journal:  Lancet       Date:  1983-04-09       Impact factor: 79.321

6.  Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3.

Authors:  P M Mendelman; J Campos; D O Chaffin; D A Serfass; A L Smith; J A Sáez-Nieto
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

7.  Penicillin-insensitive meningococci in the UK.

Authors:  E M Sutcliffe; D M Jones; S el-Sheikh; A Percival
Journal:  Lancet       Date:  1988-03-19       Impact factor: 79.321

8.  Penicillin-resistant Neisseria meningitidis in southern Africa.

Authors:  P Botha
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

Review 9.  Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989).

Authors:  J A Sáez-Nieto; R Lujan; S Berrón; J Campos; M Viñas; C Fusté; J A Vazquez; Q Y Zhang; L D Bowler; J V Martinez-Suarez
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

Review 10.  Horizontal genetic exchange, evolution, and spread of antibiotic resistance in bacteria.

Authors:  M C Maiden
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079
View more
  7 in total

1.  Sequencing of Neisseria meningitidis penA gene: the key to success in defining penicillin G breakpoints.

Authors:  Luisa Arreaza; Celia Salcedo; Belén Alcalá; María José Uría; Raquel Abad; Rocío Enríquez; Julio A Vázquez
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections.

Authors:  Julio A Vázquez; Luisa Arreaza; Colin Block; Ingrid Ehrhard; Stephen J Gray; Sigrid Heuberger; Steen Hoffmann; Paula Kriz; Pierre Nicolas; Per Olcen; Anna Skoczynska; Lodewijk Spanjaard; Paola Stefanelli; Muhamed-Kheir Taha; Georgina Tzanakaki
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

3.  Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents.

Authors:  James H Jorgensen; Sharon A Crawford; Kristin R Fiebelkorn
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Antimicrobial susceptibility, serotype and genotype distribution of meningococci in Portugal, 2001-2002.

Authors:  E Ferreira; R Dias; M Caniça
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

5.  Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.

Authors:  Brian H Harcourt; Raydel D Anderson; Henry M Wu; Amanda C Cohn; Jessica R MacNeil; Thomas H Taylor; Xin Wang; Thomas A Clark; Nancy E Messonnier; Leonard W Mayer
Journal:  Open Forum Infect Dis       Date:  2015-08-13       Impact factor: 3.835

6.  Design, synthesis, and structural elucidation of novel NmeNANAS inhibitors for the treatment of meningococcal infection.

Authors:  Osama I Alwassil; Sandeep Chandrashekharappa; Susanta K Nayak; Katharigatta N Venugopala
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

7.  Selected commensals educate the intestinal vascular and immune system for immunocompetence.

Authors:  Rossana Romero; Agnieszka Zarzycka; Mathieu Preussner; Florence Fischer; Torsten Hain; Jan-Paul Herrmann; Katrin Roth; Corinna U Keber; Kushal Suryamohan; Hartmann Raifer; Maik Luu; Hanna Leister; Wilhelm Bertrams; Matthias Klein; Hosam Shams-Eldin; Ralf Jacob; Hans-Joachim Mollenkopf; Krishnaraj Rajalingam; Alexander Visekruna; Ulrich Steinhoff
Journal:  Microbiome       Date:  2022-09-28       Impact factor: 16.837
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.